Carotid intima-media thickness in individuals with and without type 2 diabetes: and reproducibility study

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Lundby Christensen, Louise ^a   Almdal, Thomas P ^a   Carstensen, Bendix ^a   Tarnow, Lise ^a   Wiinberg, Niels ^b  

^a STENO DIABETES CENTER   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CLINICAL EXAMINATION; COMMON CAROTID ARTERY; COMPUTER PROGRAM; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REPRODUCIBILITY; ULTRAVIOLET B RADIATION; AGED; CAROTID ARTERY DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; INTIMA; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE; STANDARD; STATISTICS; TUNICA MEDIA; VALIDATION STUDY;

ADULT; AGED; CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TUNICA INTIMA; TUNICA MEDIA; ULTRASONOGRAPHY;

EID: 77955678597     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-40     Document Type: Article

References (31)

1. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997, 96:1432-1437.
2. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, Rosamond WD, Evans G. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. American Journal of Epidemiology 2000, 151:478-487.
3. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22. 10.1056/NEJM199901073400103, 9878640.
4. Touboul PJ, Labreuche J, Vicaut E, Amarenco P, . on behalf of the GENIC Investigators Carotid Intima-Media Thickness, Plaques, and Framingham Risk Score as Independent Determinants of Stroke Risk. Stroke 2005, 36:1741-1745. 10.1161/01.STR.0000174490.23495.57, 16020769, on behalf of the GENIC Investigators.
5. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y, Kosugi K, Shimizu Y, Kawamori R, Hori M. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 2000, 23:1310-1315. 10.2337/diacare.23.9.1310, 10977024.
6. Boissel JP, Collet JP, Moleur P, Haugh M. Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol 1992, 43:235-244. 10.1007/BF02333016, 1425885.
7. Bots ML, Palmer MK, Dogan S, Plantinga Y, Raichlen JS, Evans GW, O'Leary DH, Grobbee DE, Crouse I. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. J Intern Med 2009, 265(6):698-707. 10.1111/j.1365-2796.2009.02073.x, 19298496.
8. Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML, . for the METEOR Study Group Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals With Subclinical Atherosclerosis: The METEOR Trial. JAMA: The Journal of the American Medical Association 2007, 297:1344-1353. 10.1001/jama.297.12.1344, 17384434, for the METEOR Study Group.
9. Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, Henderson JA, Howard WJ, Lee ET, Mete M, Poolaw B, Ratner RE, Russell M, Silverman A, Stylianou M, Umans JG, Wang W, Weir MR, Weissman NJ, Wilson C, Yeh F, Zhu J. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA: The Journal of the American Medical Association 2008, 299:1678-1689. 10.1001/jama.299.14.1678, 18398080.
10. Katakami N, Yamasaki Y, Hayaishi-Okano R, Ohtoshi K, Kaneto H, Matsuhisa M, Kosugi K, Hori M. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Diabetologia 2004, 47:1906-1913. 10.1007/s00125-004-1547-8, 15565373.
11. Kodama M, Yamasaki Y, Sakamoto K, Yoshioka R, Matsuhisa M, Kajimoto Y, Kosugi K, Ueda N, Hori M. Antiplatelet Drugs Attenuate Progression of Carotid Intima-Media Thickness in Subjects with Type 2 Diabetes. Thrombosis Research 2000, 97:239-245. 10.1016/S0049-3848(99)00168-1, 10674411.
12. Matsumoto K, Sera Y, Abe Y, Tominaga T, Yeki Y, Miyake S. Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. Diabetes Res Clin Pract 2004, 64:225-228. 10.1016/j.diabres.2003.11.007, 15126012.
13. Fleiss JL. The design and analysis of clinical experiments. 1986, John Wiley and sons, Inc, New York.
14. Gepner AD, Korcarz CE, Aeschlimann SE, LeCaire TJ, Palta M, Tzou WS, Stein JH. Validation of a carotid intima-media thickness border detection program for use in an office setting. J Am Soc Echocardiogr 2006, 19:223-228. 10.1016/j.echo.2005.09.006, 16455429.
15. Lim TK, Lim E, Dwivedi G, Kooner J, Senior R. Normal Value of Carotid Intima-Media Thickness-A Surrogate Marker of Atherosclersosis: Quantitative Assessment by B-Mode Carotid Ultrasound. Journal of the American Society of Echocardiography 2008, 21:112-116. 10.1016/j.echo.2007.05.002, 17764896.
16. Touboul PJ, Vicaut E, Labreuche J, Belliard JP, Cohen S, Kownator S, Pithois-Merli I. Design, baseline characteristics and carotid intima-media thickness reproducibility in the PARC study. Cerebrovasc Dis 2005, 19:57-63. 10.1159/000081913, 15528886.
17. Langenfeld MR, Forst T, Hohberg C, Kann P, Lubben G, Konrad T, Fullert SD, Sachara C, Pfutzner A. Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study. Circulation 2005, 111:2525-2531. 10.1161/01.CIR.0000165072.01672.21, 15883215.
18. Yokoyama H, Katakami N, Yamasaki Y. Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus. Stroke 2006, 37:2420-2427. 10.1161/01.STR.0000236632.58323.cd, 16888250.
19. Hosomi N, Mizushige K, Ohyama H, Takahashi T, Kitadai M, Hatanaka Y, Matsuo H, Kohno M, Koziol JA. Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus. Stroke 2001, 32:1539-1545.
20. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004, 164:1422-1426. 10.1001/archinte.164.13.1422, 15249351.
21. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006, 368:29-36. 10.1016/S0140-6736(06)68967-8, 16815377.
22. Bonora E, Kiechl S, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M, Willeit J. Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia 2000, 43:156-164. 10.1007/s001250050024, 10753036.
23. Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M. Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. Stroke 1996, 27:1986-1992.
24. Lee CD, Folsom AR, Pankow JS, Brancati FL. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 2004, 109:855-860. 10.1161/01.CIR.0000116389.61864.DE, 14757692.
25. de Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F, Bots ML, Kastelein JJ. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 2008, 5:280-288. 10.1038/ncpcardio1163, 18332891.
26. Meuwese MC, de GE, Duivenvoorden R, Trip MD, Ose L, Maritz FJ, Basart DC, Kastelein JJ, Habib R, Davidson MH, Zwinderman AH, Schwocho LR, Stein EA. ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial. JAMA: The Journal of the American Medical Association 2009, 301:1131-1139. 10.1001/jama.301.11.1131, 19293413.
27. Montauban van Swijndregt AD, De Lange EE, de Groot E, Ackerstaff RGA. An in vivo evaluation of the reproducibility of intima-media thickness measurements of the carotid artery segments using B-mode ultrasound. Ultrasound in Medicine & Biology 1999, 25:323-330.
28. Baumann M, Richart T, Sollinger D, Pelisek J, Roos M, Kouznetsova T, Eckstein HH, Heemann U, Staessen JA. Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML). Cardiovasc Diabetol 2009, 8:45. 10.1186/1475-2840-8-45, 2733133, 19660101.
29. Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, Togane M. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol 2010, 9:18. 10.1186/1475-2840-9-18, 2877657, 20470427.
30. Keech AC, Grieve SM, Patel A, Griffiths K, Skilton M, Watts GF, Marwick TH, Groshens M, Celermajer DS. Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy. Diabet Med 2005, 22:1558-1565. 10.1111/j.1464-5491.2005.01688.x, 16241922.
31. Yokoyama H, Aoki T, Imahori M, Kuramitsu M. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int 2004, 66:448-454. 10.1111/j.1523-1755.2004.00752.x, 15200455.